Table 6.
Variable | Multivariable SHR (95% CI) | P valueb |
---|---|---|
HPS | 0.41 (0.31–0.55) | <.001 |
Age at listingc | 1.27 (1.23–1.31) | <.001 |
Male sex | 0.85 (0.79–0.92) | <.001 |
Race/ethnicity | <.001 | |
White | 1 | |
Black | 0.86 (0.78–0.95) | |
Hispanic | 1.10 (0.98–1.25) | |
Asian | 1.05 (0.97–1.12) | |
Other | 1.12 (0.92–1.35) | |
Initial laboratory MELD scored | 1.03 (1.02–1.03) | <.001 |
Primary diagnosis | <.001 | |
Hepatitis C | 1 | |
Alcohol | 0.80 (0.77–0.83) | |
Hepatitis B | 0.82 (0.74–0.91) | |
NASH/cryptogenic | 0.80 (0.74–0.87) | |
Cholestatic | 0.74 (0.67–0.82) | |
Autoimmune | 0.81 (0.75–0.87) | |
Other | 1.00 (0.89–1.12) | |
Ascites before listing | 1.23 (1.12–1.34) | <.001 |
Blood type | ||
O | 1 | <.001 |
A | 0.97 (0.92–1.02) | |
B | 0.79 (0.73–0.86) | |
AB | 0.49 (0.44–0.55) | |
Initial serum albumin | 0.74 (0.69–0.79) | <.001 |
NASH, nonalcoholic steatohepatitis.
Competing risk Cox regression model, treating transplantation as a competing risk. Results reported as sub-hazard ratios (SHRs) instead of hazard ratios.
P value for multivariable hazard ratio.
Hazard for every increase in 10 years at listing.
SHR represents increased risk for every 1 MELD point.